Diabetes News and Research

Latest Diabetes News and Research

Radiation therapy puts childhood cancer survivors at higher risk of cardiometabolic disease

Decades after battling childhood cancer, survivors often face a new challenge: cardiometabolic disease. A spectrum of conditions that includes coronary heart disease and diabetes, cardiometabolic disease typically impacts people who are obese, elderly, or insulin resistant.

9 Nov 2021

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Researchers at the University of Toronto and Unity Health Toronto have demonstrated that repeated listening to personally meaningful music induces beneficial brain plasticity in patients with mild cognitive impairment or early Alzheimer's disease.

9 Nov 2021

Early or late bedtimes may cause adverse consequences for cardiovascular health

Going to sleep between 10:00 and 11:00 pm is associated with a lower risk of developing heart disease compared to earlier or later bedtimes, according to a study published today in European Heart Journal – Digital Health, a journal of the European Society of Cardiology.

9 Nov 2021

New campaign shows how prediabetes can be reversed

Prediabetes can be reversed – and the American Medical Association, the Centers for Disease Control and Prevention, and the Ad Council want people to know it.

9 Nov 2021

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Among the populations most significantly affected by COVID-19 are the elderly and patients with preexisting medical conditions including diabetes, hypertension, obesity, metabolic syndrome, cardiovascular disease and chronic lung diseases like COPD and asthma.

8 Nov 2021

Hispanic adults with peripheral artery disease more likely to be admitted to the hospital through the ER

Hispanics adults hospitalized for treatment of symptoms of peripheral artery disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes (QCOR) Research Scientific Sessions 2021.

8 Nov 2021

Researchers link elevated levels of galectin-1 with increased risk of type 2 diabetes

Researchers at the University of Gothenburg now associate elevated levels of the protein galectin-1 with increased risk of developing type 2 diabetes about 18 years later.

8 Nov 2021

Study highlights the importance of reducing air pollution to prevent heart attacks

Reduced air pollution in the U.S. during the COVID-19 shutdown initiated in March 2020 was linked to fewer severe heart attacks, according to preliminary research to be presented at the American Heart Association's Scientific Sessions 2021.

8 Nov 2021

The importance of exercise for those with diabetes in the COVID era

A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.

7 Nov 2021

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits for people with type 2 diabetes.

7 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Diabetes medication reduces the rate of kidney function decline in CKD patients

Clinical trial data reveal that dapagliflozin - a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes - reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2021 November 4–November 7.

7 Nov 2021

Middlemen take home almost 53% of the net proceeds from insulin sales, finds study

Despite its discovery nearly 100 years ago, insulin's list price has been going up, not down, with trade secrets and other protections preventing researchers from pinpointing who is receiving profits from its sale.

7 Nov 2021

Therapeutics that target ceramides may help treat cardiometabolic disease

Therapeutics that target lipids called ceramides might hold potential for treating cardiometabolic disease, argues a review article published November 5th in the journal Trends in Pharmacological Sciences.

7 Nov 2021

Results of high-impact clinical trials could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented online at ASN Kidney Week 2021 November 4–November 7.

7 Nov 2021

Experts gain insights into pathomechanisms of dilated cardiomyopathy

Titin is a "titanically large" protein – the largest in the human body – which enables elastic movements of our muscles, including the heart.

6 Nov 2021

Study identifies serotonin as a possible trigger of flare-ups in Crohn's disease

A new treatment may be on the horizon for people with a major form of inflammatory bowel disease (IBD) called Crohn's disease, after a McMaster University-led study identified serotonin as a possible trigger of flare-ups.

6 Nov 2021

Despite restraints, democrats’ drug pricing plan could still aid consumers

The Medicare prescription drug pricing plan Democrats unveiled this week is not nearly as ambitious as many lawmakers sought, but they and drug policy experts say the provisions crack open the door to reforms that could have dramatic effects.

5 Nov 2021

MHRA approves first oral antiviral for the treatment of COVID-19

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency announced today.

4 Nov 2021

Study finds benefits of COVID vaccination in pregnancy outweighs risks

A new preprint explores the efficacy of vaccination against infection with SARS-CoV-2 in pregnancy.

4 Nov 2021

Diabetes News and Research

Latest Diabetes News and Research

Radiation therapy puts childhood cancer survivors at higher risk of cardiometabolic disease

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Early or late bedtimes may cause adverse consequences for cardiovascular health

New campaign shows how prediabetes can be reversed

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Hispanic adults with peripheral artery disease more likely to be admitted to the hospital through the ER

Researchers link elevated levels of galectin-1 with increased risk of type 2 diabetes

Study highlights the importance of reducing air pollution to prevent heart attacks

The importance of exercise for those with diabetes in the COVID era

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

Diabetes medication reduces the rate of kidney function decline in CKD patients

Middlemen take home almost 53% of the net proceeds from insulin sales, finds study

Therapeutics that target ceramides may help treat cardiometabolic disease

Results of high-impact clinical trials could affect kidney-related medical care

Experts gain insights into pathomechanisms of dilated cardiomyopathy

Study identifies serotonin as a possible trigger of flare-ups in Crohn's disease

Despite restraints, democrats’ drug pricing plan could still aid consumers

MHRA approves first oral antiviral for the treatment of COVID-19

Study finds benefits of COVID vaccination in pregnancy outweighs risks

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in